Tachycardia News

News

Existing risk scores not enough to predict AF outcomes after pulmonary vein isolation

20211002060000

Currently available risk scores are unreliable for predicting recurrent atrial fibrillation (AF) after initial radiofrequency pulmonary vein isolation, a new study has found.

New ESC guidelines zero in on lipids, diabetes, and more

Elvira Manzano, Roshini Claire Anthony, 20191001070306

The European Society of Cardiology (ESC) has released five new guidelines at the ESC Congress 2019, recommending an even lower LDL-C* target in patients at very high risk for cardiovascular disease (CVD), and the use of SGLT2** inhibitors and GLP-1*** receptor agonists as first-line treatments in those with diabetes to reduce their CVD risk.

Wearable defibrillators suitable for children with ventricular arrhythmia

Roshini Claire Anthony, 20180724140300

The use of a wearable cardioverter-defibrillator (WCD) may be a suitable alternative for paediatric patients with life-threatening ventricular arrhythmias who are not candidates for implantable cardioverter-defibrillators (ICDs), a recent study showed.

Product Highlight - VIACORAM

16 Jun 2021

Perindopril arginine 3.5 mg,
Amlodipine besilate 2.5 mg tab

Ticagrelor monotherapy outshines DAPT after complex PCI

Audrey Abella, 23 Apr 2020

Among patients undergoing complex percutaneous coronary intervention (PCI) who completed 3 months of dual antiplatelet therapy (DAPT) comprising aspirin and the potent P2Y12-receptor inhibitor ticagrelor, aspirin withdrawal led to fewer bleeding episodes without increasing the risk of ischaemic events compared with continued DAPT, according to data from the TWILIGHT-COMPLEX* subanalysis presented at ACC.20/WCC Virtual.

Empagliflozin’s cardiovascular benefits lead the change in T2D treatment paradigm

11 May 2020

This second issue revisits the impact EMPA-REG OUTCOME had on clinical practice and helps readers discover how it gives life back to patients through its cardiovascular indication. Learn how it was approved and the possible mechanisms for its cardiovascular benefits.